Review of preclinical feasibility for EEG-phase-controlled iTBS stimulation
This publication is a preclinical technical feasibility review rather than a clinical trial. The scope focuses on the technical implementation of prefrontal EEG-phase-controlled intermittent theta burst stimulation. The authors propose a seed-and-sustain hypothesis regarding the stimulation mechanism. No specific patient populations or clinical outcomes are described because the study is preclinical.
The review highlights significant technical challenges. Within-train stimulation pulses corrupt real-time EEG signals. Additionally, there is a general difficulty in predicting EEG theta phase even to initiate an iTBS train. These factors complicate the precise delivery of the intended stimulation protocol.
The authors emphasize that future human trials will be needed to evaluate the practical benefits of this approach. Safety data, adverse events, and tolerability were not reported in this preclinical context. The review concludes that clinical efficacy cannot be claimed at this stage.
Practice relevance is limited to the need for further investigation. Clinicians should not infer specific patient populations or outcomes from this preclinical work. The review serves to outline technical hurdles before human application.